Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359016 · ClinicalTrials.gov registry record · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
A NA study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 14,600
- Enrollment target
- 1
- Study location
NCT05359016: Recruiting NA study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
NCT05359016 is a NA study of Cervical Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 14,600 participants, above the 469-participant average among 144 other Cervical Cancer trials with a reported enrollment target (3013% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05359016, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 14,600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.
Conditions Studied
Interventions
- BEHAVIORAL HPV testing of women for cervical cancer screening
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,600 participants |
| Start Date | 2020-12-22 |
| Est. Completion | 2027-02-02 |
| Phase | NA |
What NCT05359016 shows while recruiting
NCT05359016 is an interventional study that assigns participants to a tested intervention. Its 14,600 participants enrollment target places it among the larger protocols in the corpus, above the 469-participant average among 144 other Cervical Cancer trials with a reported enrollment target (3013% higher).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which HPV testing of women for cervical cancer screening is the first listed.
NCT05359016 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05359016 about?
NCT05359016 is a clinical study titled "Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique". The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed bel...
What is the current status of trial NCT05359016?
This trial is currently recruiting. It is a NA study. The enrollment target is 14,600 participants. The study started on 2020-12-22. Estimated completion is 2027-02-02.
What conditions does trial NCT05359016 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT05359016?
The interventions under investigation include: HPV testing of women for cervical cancer screening (BEHAVIORAL).
Who is sponsoring clinical trial NCT05359016?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05359016 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05359016's enrollment target sits among peer trials
14,600 1st of 144 higher than 144 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI